CDK4 and sarcoma: In this study, we evaluate the antitumor effect of XVir-N-31 and adenovirus wild type (ADWT) in combination with different CDK4/6i in vitro in a panel of bladder cancer and sarcoma cell lines and in murine xenograft sarcoma mouse models.